ZLD 2.86% 36.0¢ zelira therapeutics limited

Ann: EMD:Emyria Enters Data Deal with ZLD to Support Autism Trial, page-9

  1. 201 Posts.
    lightbulb Created with Sketch. 84
    this is important to watch indeed, I believe this is what kept the price low recently. The biggest issue with Zelira at the moment is this constant adding of new shares, hopefully they stop that soon before long time holders are fed up.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.